Here are four things to know.
1. Specialty drug spending increased by 13.7 percent last year, which was offset by a 1.7 percent decrease in spending on traditional drugs, according to a news release.
2. The PBM achieved a 5 percent reduction in the average cost per generic prescription for 2016 and its members increased generic utilization from 83.1 to 84.7 percent last year.
3. Prime Therapeutic members saved a combined amount of $2.2 billion in 2016.
4. The company cited several factors that contributed to the low rate of increase for drug spending in 2016, such as members’ use of PBM programs, more reliance on generics and better industry alignment and innovative partnerships.
More articles on supply chain:
Integra to buy J&J’s neurosurgery business for $1B
Winter storms exacerbate blood shortage in New England
Sen. Sanders to drugmaker: ‘We’re going to be your worst nightmare’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
